Cardiology Clinical Trials
|
|
Study
|
Description
|
| ASCEND - HF |
The purpose of this study is to evaluate whether treatment with the IV drug Natrecor improves Heart Failure symptoms. |
| PROTECT |
This study compares the rate of cardiac stent thrombosis using different types of stents. |
| PROTECT CA |
To evaluate overall stent thrombosis rate using the Endeavor Zotarolimus Eluting Coronary Stent System in patients requiring stent implantation. |
| PLATINUM |
To purpose of this study is to evaluate the safety and effectiveness of the PROMUS Element Everolimus Eluting Coronary System (Boston Scientific Corp). |
| MADIT CRT |
This study is to determine if people who have impaired heart function will have improved survival and less heart failure with an automatic defibrillator device that can also pace the heart efficiently. |
| SOLID 52 |
The primary objective of this study is to evaluate long-term treatment with Darapladib Enteric Coated Tablets when added to standard of care in an acute coronary syndrome (ACS) patients. |
| PACE-MI |
The PACE-MI registry is a non-voluntary registry of all patients diagnosed with Myocardial Infarction (MI). In patients with MI discharged from the hospital, beta-blocker dose will be predictive of survival. |
| Hyponatremia Registry |
A registry that identifies patients hospitalized with hyponatremia and compares the effectiveness of available treatments. |
| Comparison of Angio Seal and Mynx vascular closure devices after cardiac catheterization via femoral artery |
The purpose of the study is to investigate the difference of two FDA-approved vascular closure devices, the Angio Seal and Mynx, after cardiac catheterization. |